#circulating tumor

The global circulating tumor cells market size is anticipated to reach USD 17.56 billion by 2025 growing at a CAGR of 15.0% during the forecast period, according to a new report by Grand View Research, Inc. Introduction of novel technologies for enumeration of CTC is anticipated to fuel the market growth. Rising cases of chronic oncology diseases that depend on CTC detection and analysis, as it has enormous potential in real-time monitoring of cancer therapy over methods like imaging technologies and tumor tissue biopsy, will also drive the market.

Additionally, application of CTC as biomarkers for drug discovery is a promising factor for growth in the coming years. Utilization of the CTCs in the development of tumor-specific biomarkers to optimize the selection of targeted therapies and assessment of better response to the therapy is expected to support in the market growth. CTC enrichment accounted for the largest revenue share of the global market in 2018 and is expected to continue the dominance throughout the forecast period. This is due to extensive usage in oncology research establishments and high accuracy exhibited by this technology.

Microchips technology is anticipated to register the highest CAGR owing to the introduction of cluster chip technology that helps capture the clusters of tumor cells for CTC quantitation. Cancer stem cell research segment accounts for the largest revenue share of the market. Properties of the cancer stem cells of self-renewal in replenishing the growing cancer is driving the attention of organizations and researchers in CTC cancer stem cell research segment.

Request Free Sample PDF of the research at: https://www.grandviewresearch.com/industry-analysis/circulating-tumor-cells-market/request/rs1

Other key findings from the study suggest:

Application of alterations in the expression profiles of EMT-associated transcriptional regulators and their molecular targets as biomarkers in EMT study is expected to serve as an impetus for diagnosis of tumor

North America led the CTC market in 2018 due to rising cases of cancer, oncology research funding, and favorable government initiatives for clinical diagnostic products

APAC is anticipated to witness the highest CAGR of over 16% from 2019 to 2025 due to infrastructural development in care centers and increased sales of CTC diagnostic tests

Rising need for new diagnosis methods for cancer has encouraged R&D in developing economies of APAC. This will help expand the region further

Fluxion Biosciences, Inc.; AdnaGen AG; Biocept, Inc.; Ikonisys, Inc.; and Sysmex Corp. are some of the key industry participants

Global Circulating Tumor Cells Industry 2016 Market Overview, Size, Share, Trends, Analysis, Technology, Applications, Growth, Market Status, Demands, Insights, Development, Research and Forecast 2016-2020.

A new intelligence study presents a comprehensive overview of the global Circulating Tumor Cells market, offering insights into the key growth factors and lucrative opportunities. In addition, the key regional segments, product segmentation, and the primary applications have been discussed at length in the scope of the research report. The research report, with a view to offer a clear understanding of the global Circulating Tumor Cells market, provides a detailed information regarding the key growth factors, current trends, recent developments, and the limitations faced by the prominent players operating in the overall market.

To Get Sample Copy of Report visit @ http://www.qyresearchreports.com/sample/sample.php?rep_id=903598&type=E

The research report has furnished answers to several burning questions concerning the growth and development of the global Circulating Tumor Cells market. Some of them are given below:

Which product segment is expected to lead in the global Circulating Tumor Cells market? What is the anticipated growth rate of the global Circulating Tumor Cells market in the forecast period? Which regional segment is estimated to account for a massive share of the global Circulating Tumor Cells market? What are the primary driving factors of the global Circulating Tumor Cells market? What are the vital challenges faced by the prominent players in the global Circulating Tumor Cells market? Which current trends are likely to offer promising growth prospects in the next few years? How is the competitive landscape of the global Circulating Tumor Cells market at present?

Furthermore, the study offers a detailed overview of the global Circulating Tumor Cells market in terms of the competitive scenario. A list of all the leading players operating in the global Circulating Tumor Cells market has been listed in the study, along with the key strategies that are being used by them in order to flourish and sustain in the market. Additionally, the company profiles, product portfolio, financial overview, SWOT analysis, mergers and acquisitions, and the latest developments have been discussed in the research study to offer a strong understanding of the global Circulating Tumor Cells market.

Browse Complete Report with TOC @ http://www.qyresearchreports.com/report/global-circulating-tumor-cells-market-research-report-2016.htm

Table of Contents

1 Circulating Tumor Cells Market Overview 1 1.1 Product Overview and Scope of Circulating Tumor Cells 1 1.2 Circulating Tumor Cells Segment by Types 2 1.2.1 Global Production Market Share of Circulating Tumor Cells by Types in 2015 2 1.2.2 CTC enrichment 3 1.2.3 CTC detection 4 1.2.4 CTC analysis 5 1.3 Circulating Tumor Cells Segment by Applications 6 1.3.1 Circulating Tumor Cells Consumption Market Share by Applications in 2015 6 1.3.2 Characteristics of Circulating Tumor Cells (CTCs) 9 1.4 Circulating Tumor Cells Market by Regions 9 1.4.1 North America Status and Prospect (2011-2021) 9 1.4.2 Europe Status and Prospect (2011-2021) 10 1.4.3 China Status and Prospect (2011-2021) 11 1.4.4 Asia-Pacific (EX. Europe) Status and Prospect (2011-2021) 12 1.5 Global Market Size (Value) of Circulating Tumor Cells (2011-2021) 13

2 Global Circulating Tumor Cells Market Competition by Manufacturers 14 2.1 Global Circulating Tumor Cells Revenue and Share by Manufacturers (2015 and 2016) 14 2.2 Manufacturers Circulating Tumor Cells Manufacturing Base Distribution, Sales Area, Product Types 18 2.3 Circulating Tumor Cells Market Competitive Situation and Trends 19 2.5.1 Circulating Tumor Cells Market Concentration Rate 19 2.5.2 Circulating Tumor Cells Market Share of Top 3 and Top 5 Manufacturers 20 2.5.3 Circulating Tumor Cells Market Competitive Situation 21 2.5.4 Circulating Tumor Cells Market Trends 21

3 Global Circulating Tumor Cells Revenue, Revenue (Value) by Regions (2011-2016) 23 3.1 Global Circulating Tumor Cells Revenue and Market Share by Regions (2011-2016) 23 3.3 Global Circulating Tumor Cells Revenue, Gross Profit and Gross Margin (2011-2016) 25 3.4 North America Circulating Tumor Cells Revenue, Gross Profit and Gross Margin (2011-2016) 25 3.5 China Circulating Tumor Cells Revenue, Gross Profit and Gross Margin (2011-2016) 25 3.6 Europe Circulating Tumor Cells Revenue, Gross Profit and Gross Margin (2011-2016) 26 3.7 Asia-Pacific (EX. Europe) Circulating Tumor Cells Revenue, Gross Profit and Gross Margin (2011-2016) 26

For Market Research Latest Reports Visit @ http://www.qyresearchreports.com/reports.htm

Contact Us